Report: Women have fewer procedures after heart attack than men
01 October 2015
Amid a growing body of research on heart health devices and blood pressure monitoring, a new report from Blue Cross Blue Shield shows that women undergo fewer diagnostic procedures and treatments following a heart attack than men.
New Study Reveals Immunotherapy More Effective Than Chemotherapy
01 October 2015
Study results published in the New England Journal of Medicine comparing the efficacy of an immunotherapy with chemotherapy as a second-line treatment for nonsquamous non–small-cell lung cancer (NSCLC) signal a potential turning point in the therapeutic landscape of cancer.
Moscow and federal funds invest in biosolutions for diagnostics and research
01 October 2015
The Moscow Seed Fund and the RVC Biofund, an investment arm of RVC, Russia’s fund of funds for innovation, have anted up $180,000 in Central Factory of Prepared Solutions (CFPS), a Russian company, the RVC website announced .
Russia Among Top Countries Progressing in Fight Against Non-communicable Disease
30 September 2015
The World Health Organization said that Russia is one of the world’s 10 countries that have shown the best progress in the fighting against non-communicable disease this year.
Feds prioritize researcher access to health data in IT action plan
30 September 2015
Federal officials are to prioritize making high-quality electronic health data more readily available to researchers over the next 5 years. Objectives include increased use of trial data in patient-focused outcomes studies, the application of health IT to improve clinical research and greater openness.
NEJM: FDA's proposed risk-disclosure guidelines still aren't enough
30 September 2015
As the FDA again reviews its guidance on disclosing prescription drug risk information, two New England Journal of Medicine articles are suspicious that new guidelines would change much for patients.
New breast cancer solution enters preclinical trials in St. Pete
30 September 2015
Biocad, an innovative developer in St. Petersburg, announced the launch of a preclinical trial phase for its new breast cancer solution. The drug candidate is expected to show efficacy in fighting the disease at both early and advanced stages.
How much more does the U.S. pay for drugs? Up to 10 times more, report says
29 September 2015
Skyrocketing drug prices are triggering a firestorm of criticism, with lawmakers and the public calling for new reforms. A common point: Drugs cost more in the U.S. than in other countries that use cost assessments and price caps to keep a lid on costs.
UK scientists start stem cell trial of potential blindness cure
29 September 2015
The first patient has been treated in Britain in a pioneering trial of a new treatment co-developed by Pfizer and derived from embryonic stem cells designed for patients with a condition that can cause blindness.
World's largest reinsurer ready to insure against FDA actions
29 September 2015
If a pharma plant closes because of an explosion or a natural disaster, well there is business interruption insurance for that. But if it closes to deal with issues after the FDA issues a Form 483 or a warning letter, then the drugmaker is on the hook for all of the costs. Now a couple of insurance companies say they will offer something to soften such blows.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024